Clinical Trials Browser

Phase 3 × Anal Canal Carcinoma × Immune Checkpoint Inhibitors × Clear all

NCT05374252 2022-05-16

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Phase 3 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms